Genome engineering has a new tool—endonucleases involved in bacterial adaptive immunity that can be reprogrammed with customizable small, noncoding RNAs.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Diversity of CRISPR-Cas immune systems and molecular machines
Genome Biology Open Access 09 November 2015
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Jinek, M. et al. Science advance online publication, doi:10.1126/science.1225829 (28 June 2012).
Wiedenheft, B., Sternberg, S.H. & Doudna, J.A. Nature 482, 331–338 (2012).
Deltcheva, E. et al. Nature 471, 602–607 (2011).
Garneau, J.E. et al. Nature 468, 67–71 (2010).
Makarova, K.S. et al. Nat. Rev. Microbiol. 9, 467–477 (2011).
Andersson, A.F. & Banfield, J.F. Science 320, 1047–1050 (2008).
Sapranauskas, R. et al. Nucleic Acids Res. 39, 9275–9282 (2011).
Cermak, T. et al. Nucleic Acids Res. 39, 7879–7889 (2011).
Miller, J.C. et al. Nat. Biotechnol. 29, 143–148 (2011).
Kim, E. et al. Genome Res. 22, 1327–1333 (2012).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
R.B. is an R&D director at DuPont, in the Nutrition and Health division; manages teams globally (US, France and China) responsible for genomic and ecological analyses of bacterial starter cultures and probiotics for food and feed applications; is involved in leveraging CRISPR for enhancing phage resistance in starter cultures and typing bacterial strains; and is a co-inventor on several patents related to use of CRISPR technology.
Rights and permissions
About this article
Cite this article
Barrangou, R. RNA-mediated programmable DNA cleavage. Nat Biotechnol 30, 836–838 (2012). https://doi.org/10.1038/nbt.2357
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.2357
This article is cited by
-
Utilization of the CRISPR-Cas9 Gene Editing System to Dissect Neuroinflammatory and Neuropharmacological Mechanisms in Parkinson’s Disease
Journal of Neuroimmune Pharmacology (2019)
-
Characterization and distribution of CRISPR–Cas systems in Lactobacillus sakei
Archives of Microbiology (2019)
-
Applications of CRISPR technologies in research and beyond
Nature Biotechnology (2016)
-
Genome editing for targeted improvement of plants
Plant Biotechnology Reports (2016)
-
Diversity of CRISPR-Cas immune systems and molecular machines
Genome Biology (2015)